The Value of Stillness
Health Care: Drugs
Amicus Therapeutics Inc. (FOLD: NASDAQ)
$2.46 -0.06 | -2.19%
06/19/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 43,506 | 43,506 | 45,171 | 1,665 | 1,665 | 0 | 2.95M |
| Shares Bought | 43,506 | 43,506 | 45,171 | 1,665 | 1,665 | 0 | 2.95M |
| Shares Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 38.36M | 38.38M | 36.20M | 37.61M | 37.96M | 39.31M | 36.47M |
| Shares Bought | 8.33M | 8.34M | 5.72M | 5.72M | 5.66M | 5.13M | 2.34M |
| Shares Sold | 3.93M | 3.91M | 5.01M | 4.97M | 4.95M | 5.12M | 5.10M |
Portfolios with FOLD
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserWatchlist
- ContributorStocks With Big Insider Buy...
- Contributor22 Biopharma Stocks With Br...
Latest FOLD Headlines from TheStreet
- Amicus Therapeutics Announces Full-Year 2012 Financial Results And Corporate Updates 03.12.13 | 04:03 pm
- Amicus Therapeutics To Announce Full-Year 2012 Financial Results On March 12, 2013 03.07.13 | 07:03 am
- Amicus Therapeutics Introduces Proprietary "CHART" Platform Technology 03.04.13 | 07:03 am
- Amicus Therapeutics To Present At Cowen And Company 33rd Annual Health Care Conference 02.27.13 | 04:02 pm
- A Legit Reason To Give Amicus' Fabry Drug Another Chance 02.19.13 | 06:02 am
- Amicus Therapeutics Presents Additional 6-Month Results From Phase 3 Fabry Monotherapy Study At LDN World Symposium 02.15.13 | 10:02 am
- Amicus Therapeutics Advances Chaperone-Enzyme Replacement Therapy (ERT) Combination Platform In Pompe Disease 02.14.13 | 07:02 am
- Amicus Therapeutics Presents Additional Results From Phase 2 Chaperone-Enzyme Replacement Therapy (ERT) Study For Fabry Disease At LDN World Symposium 02.13.13 | 08:02 am
- 3 Biotech Stocks Under $10 Moving Higher 02.12.13 | 02:02 pm
- Amicus Therapeutics Announces Posters And Presentations At Lysosomal Disease Network WORLD Symposium 02.07.13 | 03:02 pm
Press Releases for FOLD
- Amicus Therapeutics Joins Russell 3000® Index - PR Newswire 06.27.11 | 09:06 am
- Amicus Therapeutics To Present At Jefferies 2011 Global Healthcare Conference On Tuesday, June 7, 2011 - PR Newswire 05.31.11 | 09:05 am
- Amicus Therapeutics Announces Transition Of John F. Crowley From Chairman And Chief Executive Officer To Executive Chairman - PR Newswire 04.18.11 | 04:04 pm
- Amicus Therapeutics To Present At The 13th Annual BIO CEO And Investor Conference On Tuesday, February 15, 2011 - PR Newswire 02.10.11 | 08:02 am
- Amicus Therapeutics Initiates Phase 2 Clinical Trial Evaluating Amigal⢠Co-administered With Enzyme Replacement Therapy - PR Newswire 02.09.11 | 07:02 am
- Amicus Therapeutics To Host Its Third Quarter 2010 Financial Results Conference Call And Webcast On November 8, 2010 - PR Newswire 11.02.10 | 08:11 am
- Amicus Therapeutics To Host Conference Call And Webcast To Discuss Exclusive Worldwide Agreement With GSK To Develop And Commercialize Amigal⢠For Fabry Disease - PR Newswire 10.29.10 | 06:10 am
- Amicus Therapeutics To Present At The BIO Investor Forum On October 5, 2010 - PR Newswire 09.30.10 | 08:09 am
- Amicus Therapeutics To Present At The Canaccord Genuity 30th Annual Growth Conference On August 12, 2010 - PR Newswire 08.04.10 | 08:08 am
- Amicus Therapeutics To Host Its Second Quarter 2010 Financial Results Conference Call And Webcast On August 5, 2010 - PR Newswire 07.27.10 | 08:07 am
Partner Headlines for FOLD
- Curing Parkinson's: The Alternative Approach - Is There Money To Be Made? - Seeking Alpha 04.04.13 | 09:04 am
- After-Hours Earnings Report for March 12, 2013 : KW, DOLE, ACAD, GCA, GNMK, AVID, WSR, KTOS, GERN, ACRX, FOLD, GCAP - NASDAQ 03.12.13 | 06:03 pm
- Mid-Week Biopharma Catalyst Trades To Consider - Seeking Alpha 12.13.12 | 09:12 am
- Glaxo Invests in Nigeria - Analyst Blog - Zacks 11.28.12 | 09:11 am
- 5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments - Seeking Alpha 10.09.12 | 09:10 am
- 3 Best Biotech Stocks For This Week (Part V) - Seeking Alpha 10.08.12 | 09:10 am
- Glaxo Aims to Expand Synflorix Label - Analyst Blog - NASDAQ 09.19.12 | 03:09 pm
- Glaxo Increases Stake in RGDX - Analyst Blog - NASDAQ 09.18.12 | 09:09 pm
- Glaxo to Increase Stake in Amicus - Analyst Blog - Zacks 07.19.12 | 06:07 pm
- Healthcare Business Review: Somaxon Goes WILD, Amicus's Great DEAL - Wall St. Cheat Sheet 07.19.12 | 08:07 am
